Loading…

Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design

•CtBP1 & 2 are transcriptional coregulators that have been linked to human cancers.•Crystal structures of CtBP reveal stereochemistry of binding substrate MTOB.•Two features identified, a hydrophilic channel and key Trp, are unique to CtBP.•These results provide a basis for design of specific th...

Full description

Saved in:
Bibliographic Details
Published in:FEBS letters 2014-05, Vol.588 (9), p.1743-1748
Main Authors: Hilbert, Brendan J., Grossman, Steven R., Schiffer, Celia A., Royer, William E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•CtBP1 & 2 are transcriptional coregulators that have been linked to human cancers.•Crystal structures of CtBP reveal stereochemistry of binding substrate MTOB.•Two features identified, a hydrophilic channel and key Trp, are unique to CtBP.•These results provide a basis for design of specific therapeutic CtBP inhibitors. The oncogenic corepressors C-terminal Binding Protein (CtBP) 1 and 2 harbor regulatory d-isomer specific 2-hydroxyacid dehydrogenase (d2-HDH) domains. 4-Methylthio 2-oxobutyric acid (MTOB) exhibits substrate inhibition and can interfere with CtBP oncogenic activity in cell culture and mice. Crystal structures of human CtBP1 and CtBP2 in complex with MTOB and NAD+ revealed two key features: a conserved tryptophan that likely contributes to substrate specificity and a hydrophilic cavity that links MTOB with an NAD+ phosphate. Neither feature is present in other d2-HDH enzymes. These structures thus offer key opportunities for the development of highly selective anti-neoplastic CtBP inhibitors.
ISSN:0014-5793
1873-3468
DOI:10.1016/j.febslet.2014.03.026